ARCHIVED 1. List of Drugs for Exceptional Importation and Sale [2021-11-23]
Notice to Reader:
This is an archived list. Please refer to the most current version of this list.
Drugs included on this list are called "designated drugs" and are eligible for the exceptional importation and sale provisions provided for in the Interim Order. The list, which will be updated as required, is incorporated by reference in the IO and is maintained by Health Canada.
Supersedes: 2021-07-13
Date issued: 2021-07-15
Access archived versions of this list.
Drug or Class of Drug; Brand Name, Medicinal Ingredient(s) |
Dosage Form, Strength, Route of Administration |
Country of Origin and Identifying Code |
Name of Importer |
Batch Number |
Date |
Information to Support Safe Use Made Available by Importer |
Acyclovir; |
Solution, 500mg/10mL, Intravenous use |
United States, National Drug Code (NDC): 55150-154-10 |
Auro Pharma Inc. |
N/A |
July 30, 2020 |
Contact Auro Pharma Inc. at: |
Acyclovir; |
Solution, 1000mg/20mL, Intravenous use |
United States, National Drug Code (NDC): 55150-154-20 |
Auro Pharma Inc. |
N/A |
July 30, 2020 |
Contact Auro Pharma Inc. at: |
Azithromycin; |
Powder for solution, |
Canada, |
SteriMax Inc. |
200570110 |
May 7, 2020 |
|
Azithromycin; |
Powder for solution, |
United States, National Drug Code (NDC): 70860-100-41 |
Marcan Pharmaceuticals Inc. |
N/A |
July 28, 2020 |
Contact Marcan Pharmaceuticals Inc. at: |
Cisatracurium; |
Solution for injection, |
United States, |
Sandoz Canada Incorporated |
N/A |
June 15, 2020 |
Contact Sandoz Canada at: |
Continuous Renal |
Solution, Dialysis, |
United States, |
Baxter Corporation |
N/A |
July 12, 2021 |
Contact Baxter Corporation at: |
Continuous Renal |
Solution,Dialysis, |
United States, |
Baxter Corporation |
N/A |
July 12, 2021 |
Contact Baxter Corporation at: |
Continuous Renal Replacement Therapy Solution; PrismaSATE BGK4/2.5, Multiple Medical Ingredients |
Solution, Dialysis, Intravenous Use |
United States, License number K072908 |
Baxter Corporation |
N/A |
July 13, 2021 |
Contact Baxter Corporation at: |
Continuous Renal Replacement Therapy Solution; PrismaSATE BK0/3.5, Multiple Medical Ingredients |
Solution, Dialysis, Intravenous Use |
Mexico, License number 2369C2009 SSA |
Baxter Corporation |
N/A |
July 13, 2021 |
Contact Baxter Corporation at: |
Continuous Renal Replacement Therapy Solution; PrismaSol BGK4/2.5, Multiple Medical Ingredients |
Solution, Dialysis, Intravenous Use |
United States, NDC 24571-105-06 |
Baxter Corporation |
N/A |
July 13, 2021 |
Contact Baxter Corporation at: |
Dexmedetomidine Hydrochloride |
Solution - concentrate, 100 mcg/mL, |
Spain |
Sterinova Inc. |
N/A |
January 22, 2021 |
Contact Sterinova Inc at: |
Dexmedetomidine; |
Solution, |
Spain, |
Marcan Pharmaceuticals Inc. |
N/A |
September 3, 2020 |
Contact Marcan Pharmaceuticals Inc. at: |
Dexmedetomidine; |
Solution - concentrate, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
Contact Pfizer Canada at: |
Dexmedetomidine; |
Solution, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
Contact Pfizer Canada at: |
Fentanyl; |
Liquid solution for injection, |
Latvia, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 7, 2020 |
Contact JAMP Pharma at: |
Fentanyl; |
Liquid solution for injection, |
Malta, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 7, 2020 |
Contact JAMP Pharma at: |
Hydromorphone; |
Solution, 2mg/mL, |
Germany, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 11, 2020 |
Contact JAMP Pharma at: |
Hydromorphone; Hydromorphone Kalceks, |
Solution, 10mg/mL, |
Germany, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 11, 2020 |
Contact JAMP Pharma at: |
Hydromorphone; Hydromorphone Kalceks, |
Solution, 20mg/mL, |
Germany, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 11, 2020 |
Contact JAMP Pharma at: |
Hydromorphone; Hydromorphone Kalceks, |
Solution, 50mg/mL, |
Germany, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 11, 2020 |
Contact JAMP Pharma at: |
Ketamine; |
Solution - concentrate, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
|
Medroxyprogesterone Acetate; Depo-Provera, |
Suspension for Injection, 150 mg/mL, |
United States, National Drug Code (NDC) 0009-7376-11 |
Pfizer Canada ULC |
N/A |
March 31, 2021 |
Contact Pfizer Canada at: |
Midazolam; |
Solution, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
Contact Pfizer Canada at: |
Midazolam; |
Solution, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
Contact Pfizer Canada at: |
Midazolam; |
Solution, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
Contact Pfizer Canada at: |
Midazolam; |
Solution for injection, |
United States, |
Laboratoire Riva Inc. |
N/A |
September 3, 2020 |
Contact Laboratoire Riva Inc. at: |
Midazolam; |
Solution for injection, |
United States, |
Fresenius Kabi Canada Ltd. |
N/A |
April 17, 2020 |
Contact Fresenius Kabi Canada at: |
Midazolam; |
Solution, |
Turkey, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
June 9, 2020 |
Contact JAMP Pharma at: |
Midazolam; |
Solution, |
Turkey, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
June 9, 2020 |
Contact JAMP Pharma at: |
Morphine; |
Solution, |
United States, |
Fresenius Kabi Canada Ltd. |
N/A |
May 7, 2020 |
Contact Fresenius Kabi Canada at: |
Morphine; |
Solution, |
United States, |
Fresenius Kabi Canada Ltd. |
N/A |
May 7, 2020 |
Contact Fresenius Kabi Canada at: |
Morphine; |
Solution, |
United States, |
Fresenius Kabi Canada Ltd. |
N/A |
May 7, 2020 |
Contact Fresenius Kabi Canada at: |
Morphine; |
Solution, |
Australia, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 7, 2020 |
Contact JAMP Pharma at: |
Morphine; |
Solution, |
Australia, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 7, 2020 |
Contact JAMP Pharma at: |
Morphine; |
Solution, |
Australia, |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation |
N/A |
May 7, 2020 |
Contact JAMP Pharma at: |
Norepinephrine; |
Solution - concentrate, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
Contact Pfizer Canada at: |
Norepinephrine; |
Injection, |
United States, |
Baxter Corporation |
N/A |
May 8, 2020 |
Contact Baxter Corporation at: |
Pancuronium; |
Solution, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
|
Phenelzine Sulfate; |
Tablets, |
United States, |
Lupin Pharma Canada Limited |
N/A |
July 24, 2020 |
Contact Lupin Pharma Canada Limited at: |
Propofol; |
Emulsion, |
USA |
Omega Laboratories Limited |
N/A |
April 28, 2021 |
Contact Omega Laboratories Limited at: |
Propofol; |
Emulsion, |
Italy |
Aspen Pharmacare Inc. |
N/A |
September 18, 2020 |
Contact Aspen Pharmacare Canada Inc. at: |
Propofol; |
Solution, |
Switzerland, |
Aspen Pharmacare Canada Inc. |
N/A |
July 23, 2020 |
Contact Aspen Pharmacare Canada Inc. at: |
Propofol; |
Emulsion for injection or infusion, |
Austria and Sweden, Inner vial label: M080395 |
Fresenius Kabi Canada Ltd. |
N/A |
April 16, 2020 |
|
Propylthiouracil; |
Tablet, |
United Kingdom, |
Accelera Pharma Canada |
61096E |
August 21, 2020 |
Contact Accelera Pharma Canada at: |
Propylthiouracil; |
Tablet, |
Australia, |
Phebra Canada Inc. |
N/A |
June 18, 2020 |
|
Rocuronium Bromide; |
Solution (sterile), |
United States, |
SteriMax Inc. |
N/A |
May 1, 2020 |
|
Rocuronium; |
Solution, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
|
Rocuronium; |
Solution for injection (50mg/5mL), |
United States, |
Laboratoire Riva Inc. |
N/A |
May 8, 2020 |
|
Rocuronium; |
Solution for injection, |
United States, National Drug Code (NDC) - Vial: 72611-756-01; Carton: 72611-756-10 |
Marcan Pharmaceuticals Inc. |
N/A |
July 24, 2020 |
Contact Marcan Pharmaceuticals Inc. at: |
Rocuronium; |
Solution, |
Chile, |
Formative Pharma Inc. |
N/A |
September 18, 2020 |
Contact Formative Pharma Inc. at: |
Salbutamol; |
Metered-Dose Aerosol, |
Philippines, |
Sandoz |
N/A |
May 15, 2020 |
|
Salbutamol; |
Metered-Dose Aerosol, 100mcg per actuation, |
Spain, |
JAMP Pharma Corporation |
N/A |
May 7, 2020 |
|
Sarilumab; Kevzara, Sarilumab |
Solution for Injection, 200 mg/1.4 mL, Subcutaneous Use |
Argentina, 58.665 |
Sanofi-Aventis Canada |
N/A |
June 3, 2021 |
Sanofi Canada Head Office |
Succinylcholine Chloride; |
Solution, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
|
Succinylcholine; |
Solution for injection, |
United States, |
Sandoz Canada Inc. |
N/A |
May 20, 2020 |
Contact Sandoz Canada at: |
Timolol; |
Ophthalmic solution, |
Germany, |
Pharma |
N/A |
May 15, 2020 |
Contact Pharma Stulln at: |
Tocilizumab; Actemra, Tocilizumab |
Solution, 80 mg/4 mL, |
Switzerland, Global Trade Item Number (GTIN): 07640128015161 |
Hoffmann-La Roche |
N/A |
February 22, 2021 |
Contact Hoffmann-La Roche at: |
Tocilizumab; Actemra, Tocilizumab |
Solution, 200 mg/10 mL, |
Switzerland, Global Trade Item Number (GTIN): 00056090899314 |
Hoffmann-La Roche |
N/A |
February 22, 2021 |
Contact Hoffmann-La Roche at: |
Tocilizumab; Actemra, Tocilizumab |
Solution, 400 mg/20 mL, |
Switzerland, Global Trade Item Number (GTIN): 07640128015208 |
Hoffmann-La Roche |
N/A |
February 22, 2021 |
Contact Hoffmann-La Roche at: |
Vecuronium; |
Powder for solution, |
United States, |
Pfizer Canada ULC |
N/A |
April 17, 2020 |
Page details
- Date modified: